If this looks a bit familiar to some of you, let’s just say that it’s grant crunch time again. This should be over after today. I hope. In the meantime, one of the difficult things about science-based medicine is determining what is and isn’t quackery. While it is quite obvious that modalities such as homeopathy, […]
Category: Clinical trials
As if yesterday’s post weren’t depressing enough, last weekend I attended the annual meeting of the American Society of Clinical Oncology (ASCO) meeting in Chicago, which is part of the reason I didn’t produce much in the way of posts about a week ago. Last Sunday, while aimlessly wandering from session to session and checking […]
Share this:
Here we go again. Two months ago, I noted that Dr. Stanislaw Burzynski, the Polish expatriate physician who started out as a legitimate medical researcher and then in the late 1970s took a turn away from science-based medicine and towards being a “brave maverick doctor” through his discovery in blood and urine of substances he […]
Share this:
I happen to be out of town right now, attending the annual meeting of the American Society of Clinical Oncology in Chicago. It’s been a more—shall we say?—eventful trip than anticipated, which is why at my not-so-super-secret other blog we have a guest post today and here I will (probably) be shorter than usual. I’m […]
Share this:
Being a cancer surgeon, I realize that my tendency is to view my blogging material through the prism of cancer, particularly breast cancer, my specialty. it’s easy to forget that there are diseases every bit as horrible, some arguably even more so than the worst cancer. When I think of such diseases, it’s not surprising […]
